Ozone decomposition Catalyst: The Pharmaceutical industry's "air Purification Guardian"

The pharmaceutical industry produces a variety of harmful gases in the production process, including ozone (O). Ozone is a strong oxidizing agent that protects life in the upper atmosphere, but near the ground it is a harmful pollutant. It will stimulate the respiratory tract, causing symptoms such as cough and asthma, and long-term exposure to high concentrations of ozone in the environment will damage lung function and endanger human health.
If the ozone decomposition catalyst is not used, the exhaust gas emitted by the pharmaceutical factory will contain a large amount of ozone, which will seriously pollute the surrounding air and threaten the health of employees and residents. In addition, ozone can react with other pollutants to form secondary pollution, such as photochemical smog, which further deteriorates air quality.
Ozone-breaking catalysts are like the "air purification guardians" of the pharmaceutical industry, which can effectively solve this problem. Its main components are metal oxides such as manganese dioxide (MnO₂) and copper oxide (CuO), which are like "magicians" that can "turn waste into treasure" of ozone.
The application of ozonolysis catalyst in pharmaceutical industry is very important. It can efficiently remove ozone in exhaust gas, reduce air pollution, and protect human health and the ecological environment. With increasing environmental awareness and increasingly stringent environmental regulations, ozonolysis catalysts will play an increasingly important role in the pharmaceutical industry.